INS and Insulin resistance: Therefore, insulin resistance that manifests in patients with T2D as peripheral hyperinsulinemia and increased release of IGF1, defective binding to receptors, impaired insulin signaling in muscle, adipose tissue and liver, could also be characterized in the brain by reduced release of insulin and IGFs and results as well in impaired insulin signaling in the brain.